SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-23-013235
Filing Date
2023-04-21
Accepted
2023-04-21 16:32:19
Documents
6
Period of Report
2023-04-21

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 221704
2 cover_001.jpg GRAPHIC 7852
3 lubbert_001.jpg GRAPHIC 6655
4 monaco_001.jpg GRAPHIC 6348
5 proxy_001.jpg GRAPHIC 287925
6 proxy_002.jpg GRAPHIC 309781
  Complete submission text file 0001493152-23-013235.txt   1075148
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40943 | Film No.: 23836805
SIC: 2834 Pharmaceutical Preparations